FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Tricuspid Valve Repair Device, Percutaneously Delivered
PMA: P230007
·
Supplement: S003
·
Decision May 31, 2024
Classifications
1
FEI Numbers
3
Registration Numbers
3
Basic Information
- Device Name
- Tricuspid Valve Repair Device, Percutaneously Delivered
- Trade Name
- TriClip G4 System
- PMA Number
- P230007
- Supplement Number
- S003
- Device Class
- FDA Class 3
- Product Code
- NPS
- Generic Name
- Tricuspid valve repair device, percutaneously delivered
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- May 31, 2024
- Date Received
- May 1, 2024
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Postapproval Study Protocol
- Expedited Review
- N
Advisory Committee Statement
Approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P230007.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NPS | Tricuspid Valve Repair Device, Percutaneously Delivered | FDA class 3 | Unknown |